Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up.

Research output: Contribution to journal › Article

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up.'. Together they form a unique fingerprint.

Medicine and Dentistry